CHOP’s Hemostasis and Thrombosis Center Celebrates 50th Anniversary
Jun 7, 2023
A look back at the last five decades of treatment options to what lies ahead with additional potentially curative gene therapies.
Experts from CHOP’s Allergy Program are recognized as global leaders in the management of allergic conditions and have helped formulate many of the national guidelines used by physicians around the world.
Jun 7, 2023
A look back at the last five decades of treatment options to what lies ahead with additional potentially curative gene therapies.
Jun 8, 2023
Find out what ingredients are in COVID-19 vaccines and why. Article includes an infographic summary.
May 31, 2023
More than 100 people gathered at the Philadelphia Zoo on May 20 to celebrate patient milestones at the Wyss/Campbell Center for Thoracic Insufficiency Syndrome.
Jun 1, 2023
The study captured genetic variants at extremely low levels, and dozens of patients began new therapies as a result of the findings.
May 31, 2023
Collaboration among CHOP, Alex’s Lemonade Stand Foundation, the Pacific Pediatric Neuro-Oncology Consortium, and Children’s Brain Tumor Network paves the way for new collaborative models to accelerate discoveries.
May 30, 2023
Dr. Eric Eichenwald, CHOP’s Division Chief of Neonatology, co-authored the first national standards for neonatal care published by the American Academy of Pediatrics (AAP).
May 26, 2023
While OTC Hearing Aids may seem like an attractive and affordable option for children with hearing loss, caregivers need to be cautious when seeking appropriate amplification for their children.
May 25, 2023
IBX Foundation’s commitment to expand mental health services led to a partnership with CHOP and Girard College to create a school-based model of care.
Jun 13, 2023
The Philadelphia County Medical Society (PCMS) has awarded CHOP surgeon Holly L. Hedrick, MD the 2023 Strittmatter Award, its most prestigious scientific honor.
May 24, 2023
CHOP researchers will develop gene therapies for multiple sulfatase deficiency, a devastating lysosomal storage disorder, with the goal of first-in-human trials.